Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11551
inTEST
INTT
$149M
| $98K | ﹤0.01% |
+14,026
| New | +$116K |
|
|
WOW
11552
PUT
DELISTED
WideOpenWest
WOW
| $98K | ﹤0.01% |
19,800
-600
| -3% | -$2.76K |
|
11553
CALL
Unusual Machines
UMAC
$1.31B
| $97.9K | ﹤0.01% |
+15,300
| New | +$155K |
|
11554
PUT
Flywire
FLYW
$2.28B
| $97.8K | ﹤0.01% |
+10,300
| New | +$162K |
|
|
THRD
11555
DELISTED
Third Harmonic Bio
THRD
| $97.8K | ﹤0.01% |
28,188
+11,365
| +68% | +$55.1K |
|
11556
Invesco Municipal Income Opportunities Trust
OIA
$290M
| $97.7K | ﹤0.01% |
16,225
+3,612
| +29% | +$22K |
|
11557
CALL
Fulcrum Therapeutics
FULC
$294M
| $97.3K | ﹤0.01% |
33,800
-239,200
| -88% | -$879K |
|
|
JBIO
11558
Jade Biosciences
JBIO
$1.35B
| $97.3K | ﹤0.01% |
1,107
-543
| -33% | -$47.7K |
|
|
INZY
11559
DELISTED
Inozyme Pharma
INZY
| $97.3K | ﹤0.01% |
106,874
+45,824
| +75% | +$63.5K |
|
|
CVAC
11560
CALL
DELISTED
CureVac
CVAC
| $97K | ﹤0.01% |
35,000
+100
| +0.3% | +$348 |
|
11561
CALL
Celularity
CELU
$60.8M
| $96.9K | ﹤0.01% |
56,000
+42,700
| +321% | +$80.9K |
|
|
ETWO
11562
CALL
DELISTED
E2open Parent Holdings
ETWO
| $96.8K | ﹤0.01% |
48,400
-38,400
| -44% | -$95.3K |
|
11563
Corbus Pharmaceuticals
CRBP
$215M
| $96.7K | ﹤0.01% |
18,218
-11,596
| -39% | -$102K |
|
11564
LanzaTech
LNZA
$81.4M
| $96.2K | ﹤0.01% |
3,973
+1,960
| +97% | +$176K |
|
11565
Origin Agritech
SEED
$12M
| $96K | ﹤0.01% |
48,004
+21,176
| +79% | +$43.2K |
|
11566
CALL
MicroCloud Hologram
HOLO
$43.3M
| $95.9K | ﹤0.01% |
+2,923
| New | +$176K |
|
11567
CALL
Akebia Therapeutics
AKBA
$260M
| $95.8K | ﹤0.01% |
+49,900
| New | +$102K |
|
11568
KVH Industries
KVHI
$140M
| $95.7K | ﹤0.01% |
+18,096
| New | +$103K |
|
11569
Transact Technologies
TACT
$52.4M
| $95.7K | ﹤0.01% |
26,004
+13,884
| +115% | +$57.8K |
|
11570
PUT
Playtika
PLTK
$877M
| $95.6K | ﹤0.01% |
18,500
+4,800
| +35% | +$30.1K |
|
|
CLDT
11571
PUT
Chatham Lodging
CLDT
$622M
| $95.5K | ﹤0.01% |
+13,400
| New | +$111K |
|
|
XTKG
11572
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
| $95.4K | ﹤0.01% |
+465
| New | +$73.1K |
|
11573
Prairie Operating Co
PROP
$60.3M
| $94.8K | ﹤0.01% |
+17,726
| New | +$129K |
|
|
VLRS
11574
Controladora Vuela Compania de Aviacion
VLRS
$792M
| $94.8K | ﹤0.01% |
18,154
+8,027
| +79% | +$57.7K |
|
11575
CALL
Senseonics Holdings Inc
SENS
$497M
| $94.6K | ﹤0.01% |
7,165
+6,300
| +728% | +$104K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.